FORT WORTH, Texas, Dec. 18, 2018 /PRNewswire/ — Hope TMS Center, one of the premier mental health facilities in the Dallas-Fort Worth area, announced today that it is now treating Obsessive-Compulsive Disorder (OCD) with BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS), following its recent FDA clearance. Deep TMS became the first FDA-cleared medical device for the treatment of OCD in August, making it the first TMS system to be cleared to treat multiple brain disorders.
“We’ve always prioritized helping those that could not find an effective treatment for mental illness elsewhere,” said Dr. Diana Ghelber, the head psychiatrist at Hope TMS Center. “By offering this groundbreaking new OCD treatment in our area, we can offer BrainsWay’s revolutionary therapy to our patients who remain resistant to conventional therapies.”
In Texas, 3.8 percent suffered from a serious mental illness from 2013-2014, according to the Behavioral Health Barometer. OCD is a mental illness that causes patients to have long-lasting and uncontrollable obsessions and behaviors, that affects about 2.2 million Americans according to the American Psychiatric Association. Typically, patients suffering from OCD undergo a regimen of antidepressants and Exposure Response Prevention Therapy (ERP Therapy) to manage symptoms. However, roughly half of OCD patients do not respond to these conventional treatments. BrainsWay developed the first patented treatment that could have life changing benefits for patients suffering from OCD.
Deep TMS therapy for OCD is a minimally invasive treatment that targets the anterior cingulate cortex in the brain, known to be responsible for OCD. The treatment is applied through a padded helmet, with waves similar to the frequency of an MRI.
Hope TMS Center, previously known as the Institute for Advanced Psychiatry, specializes in the alternative treatment of mental health ailments, such as depression and OCD. The facility specializes in the application of Brain Music Therapy to treat insomnia, depression, anxiety disorders, ADHD and migraines. Dr. Ghelber is a Board-Certified Psychiatrist who worked in Israel for 18 years with patients suffering from post-traumatic stress disorder (PTSD) in various capacities including victims of terror attacks and Holocaust survivors. She is currently a principal investigator in a number of studies targeting depression. In 2017, Dr. Ghelber was a recipient of America’s Most Honored Professionals. In 2018, she was honored with the America’s Most Honored Professionals – Top 1 Percent award, and was also a Compassionate Doctor 5 Year Honoree.
About Hope TMS Center
Hope TMS Center is a mental health facility providing patients in the Dallas-Fort Worth area the latest depression and OCD treatments. It offers an integrative approach to patients including Deep TMS, ketamine infusions, medication, treatment of addiction to opioids, Brain Music Therapy and psychotherapy, with a special focus on patients with severe and treatment resistant disorders.
BrainsWay Ltd./ BrainsWay USA, is engaged in the research, development and sales and marketing of a medical system for non-invasive treatment of common brain disorders. The medical system developed and manufactured by the company is based on a unique breakthrough technology called Deep TMS, which can reach significant depth and breadth of the brain and produce broad stimulation and functional modulation of targeted brain areas. In the U.S., the Company’s device has been FDA cleared for the treatment of major depressive disorder (MDD) since 2013, and is now FDA cleared (De-Novo) for the treatment of Obsessive Compulsive Disorder (OCD). The Company’s systems have also received CE clearance and are sold worldwide for the treatment of various brain disorders.
Hope TMS Contact:
SOURCE Hope TMS Center